Generic competition pounds Sanofi-Aventis

Article Abstract:

Second-quarter net profit for French pharmaceutical firm Sanofi-Aventis SA decreased by 6.3% to reach 1.68 bil euro, due in part to competition from generic medications. Net sales dropped 2% to reach 6.94 bil.

Author: Berton, Elena

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Sanofi's profit falls 2.6%

Article Abstract:

First-quarter net profit for pharmaceutical company Sanofi-Aventis S.A. dropped 2.6% to $2.87 bil, while net sales rose by 2%. Sales gains for individual drug products are presented.

Author: Berton, Elena

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: Pharmaceutical industry, France, Company sales and earnings, Company earnings/profit, SNY, Sanofi-Aventis S.A., Financial report
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.